Vitenskapelig oversiktsartikkel/review

• Lereim, Ragnhild Reehorst; Dunn, Claire; Aamdal, Elin et al. (2024). Plasma protein dynamics during ipilimumab treatment in metastatic melanoma: associations with tumor response, adverse events and survival. (ekstern lenke)
• Dillekås, Hanna; Straume, Oddbjørn (2019). The link between wound healing and escape from tumor dormancy. (ekstern lenke)
• Johannessen, Tor-Christian Aase; Wagner, Marek; Straume, Oddbjørn et al. (2013). Tumor vasculature: the Achilles' heel of cancer?. (ekstern lenke)
• Geisler, Jürgen; Bachmann, Ingeborg M.; Nyakas, Marta Sølvi et al. (2013). Malignt melanom – diagnostikk, behandling og oppfølging i Norge. (ekstern lenke)
• Naumov, George N.; Folkman, Judah; Straume, Oddbjørn et al. (2008). Tumor-vascular interactions and tumor dormancy. (ekstern lenke)

Vitenskapelig artikkel

• Schuster, Cornelia; Akslen, Lars Andreas; Straume, Oddbjørn (2023). β2-adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma. (ekstern lenke)
• Aamdal, Elin; Skovlund, Eva; Jacobsen, Kari Dolven et al. (2022). Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment. (ekstern lenke)
• Krüger, Kristi; Silwal-Pandit, Laxmi; Wik, Elisabeth et al. (2021). Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer. (ekstern lenke)
• Aamdal, Elin; Jacobsen, Kari Dolven; Straume, Oddbjørn et al. (2021). Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up. (ekstern lenke)
• Seo, Mikyung Kelly; Straume, Oddbjørn; Akslen, Lars A. et al. (2020). HSP27 Expression as a Novel Predictive Biomarker for Bevacizumab: is it Cost Effective?. (ekstern lenke)
• Engelsen, Agnete ; Wnuk-Lipinska, Katarzyna; Bougnaud, Sébastien et al. (2020). AXL is a driver of stemness in normal mammary gland and breast cancer. (ekstern lenke)
• Demicheli, Romano; Dillekås, Hanna; Straume, Oddbjørn et al. (2019). Distant metastasis dynamics following subsequent surgeries after primary breast cancer removal . (ekstern lenke)
• Schuster, Cornelia; Akslen, Lars A.; Stokowy, Tomasz et al. (2019). Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy. (ekstern lenke)
• Pilskog, Martin; Nilsen, Gry Hilde; Beisland, Christian et al. (2019). Elevated plasma interleukin 6 predicts poor response in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. (ekstern lenke)
• Forthun, Rakel Brendsdal; Hovland, Randi; Schuster, Cornelia et al. (2019). ctDNA detected by ddPCR reveals changes in tumour load in metastatic malignant melanoma treated with bevacizumab. (ekstern lenke)
• Dillekås, Hanna; Rogers, Michael S.; Straume, Oddbjørn (2019). Are 90% of deaths from cancer caused by metastases?. (ekstern lenke)
• Jansen, Yanina Jeanne Leona; Rozeman, Elisa A. Lisette; Mason, Robert et al. (2019). Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma. (ekstern lenke)
• Pilskog, Martin; Bostad, Leif; Edelmann, Reidunn Jetne et al. (2018). Tumour cell expression of interleukin 6 receptor a is associated with response rates in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. (ekstern lenke)
• Pilskog, Martin; Beisland, Christian; Akslen, Lars A. et al. (2017). Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. (ekstern lenke)
• Haaland, Gry Sandvik; Falk, Ragnhild Sørum; Straume, Oddbjørn et al. (2017). Association of Warfarin Use With Lower Overall Cancer Incidence Among Patients Older Than 50 Years. (ekstern lenke)
• Dillekås, Hanna; Demicheli, Romano; Ardoino, Ilaria et al. (2016). The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases. (ekstern lenke)
• Schuster, Cornelia; Akslen, Lars A.; Straume, Oddbjørn (2016). Expression of Heat Shock Protein 27 in melanoma metastases is associated with overall response to bevacizumab monotherapy: Analyses of predictive markers in a clinical phase II study. (ekstern lenke)
• Tzoulis, Charalampos; Schwarzlmüller, Thomas; Gjerde, Ivar Otto et al. (2015). Excellent response of intramedullary Erdheim-Chester disease to vemurafenib: a case report. (ekstern lenke)
• Ladstein, Rita Grude; Bachmann, Ingeborg M.; Straume, Oddbjørn et al. (2014). Nestin expression is associated with aggressive cutaneous melanoma of the nodular type. (ekstern lenke)
• Dillekås, Hanna Elisabet; Transeth, Monica; Pilskog, Martin et al. (2014). Differences in metastatic patterns in relation to time between primary surgery and first relapse from breast cancer suggest synchronized growth of dormant micrometastases. (ekstern lenke)
• Rogers, Michael S.; Novak, Katherine; Zurakowski, David et al. (2014). Spontaneous reversion of the angiogenic phenotype to a nonangiogenic and dormant state in human tumors. (ekstern lenke)
• Hoem, Dag; Straume, Oddbjørn; Immervoll, Heike et al. (2013). Vascular proliferation is associated with survival in pancreatic ductal adenocarcinoma. (ekstern lenke)
• Ladstein, Rita Grude; Bachmann, Ingeborg M.; Straume, Oddbjørn et al. (2012). Prognostic Importance of the Mitotic Marker Phosphohistone H3 in Cutaneous Nodular Melanoma. (ekstern lenke)
• Schuster, Cornelia; Eikesdal, Hans Petter; Puntervoll, Hanne Eknes et al. (2012). Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension. (ekstern lenke)
• Straume, Oddbjørn; Shimamura, Takeshi; Lampa, Michael J.G. et al. (2012). Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer. (ekstern lenke)
• Arnes, Jarle; Stefansson, Ingunn Marie; Straume, Oddbjørn et al. (2012). Vascular proliferation is a prognostic factor in breast cancer. (ekstern lenke)
• Ladstein, Rita Grude; Bachmann, Ingeborg M.; Straume, Oddbjørn et al. (2012). Tumor necrosis is a prognostic factor in thick cutaneous melanoma. (ekstern lenke)
• Akslen, Lars A.; Straume, Oddbjørn; Geisler, Stephanie et al. (2011). Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer. (ekstern lenke)
• Ladstein, Rita Grude; Bachmann, Ingeborg M.; Straume, Oddbjørn et al. (2010). Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma. (ekstern lenke)
• Naumov, George N.; Folkman, Judah; Straume, Oddbjørn (2009). Tumor dormancy due to failure of angiogenesis: role of the microenvironment. (ekstern lenke)
• Naumov, George N.; Nilsson, Monique B.; Cascone, Tina et al. (2009). Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance. (ekstern lenke)
• Naumov, GN; Folkman, J; Straume, Oddbjørn (2008). Tumor dormancy due to failure of angiogenesis: role of the microenvironment. (ekstern lenke)
• Bachmann, Ingeborg M.; Ladstein, Rita Grude; Straume, Oddbjørn et al. (2008). Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas. (ekstern lenke)
• Akslen, Lars A.; Puntervoll, Hanne Eknes; Bachmann, Ingeborg M. et al. (2008). Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma. (ekstern lenke)
• Bachmann, Ingeborg Margrethe; Halvorsen, Ole Johan; Collett, Karin et al. (2006). EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. (ekstern lenke)
• Naumov, George N.; Bender, Elise; Zurakowski, David et al. (2006). A model of human tumor dormancy: An angiogenic switch from the nonangiogenic phenotype. (ekstern lenke)
• Akslen, Lars A.; Angelini, Sabrina; Straume, Oddbjørn et al. (2005). BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival. (ekstern lenke)
• Bachmann, Ingeborg; Straume, Oddbjørn; Puntervoll, Hanne Eknes et al. (2005). Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. (ekstern lenke)
• Straume, Oddbjørn; Akslen, Lars A. (2005). Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma. (ekstern lenke)
• Kumar, R; Smeds, J; Berggren, P et al. (2001). A single nucleotide polymorphism in the 3' untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare. (ekstern lenke)
• Straume, Oddbjørn; Akslen, L.A. (2001). Expression of vascular endothelial growth factor, its receptors (FLT-1. KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas. (ekstern lenke)
• Straume, Oddbjørn; Sviland, L.; Akslen, L.A. (2000). Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma. (ekstern lenke)
• Vuhahula, E; Straume, Oddbjørn; Akslen, Lars A. (2000). Frequent loss of p16 protein expression and high proliferative activity (Ki-67) in malignant melanoma from black Africans. (ekstern lenke)
• Straume, Oddbjørn; Akslen, Lars A. (1999). Loss of nuclear expression of p16 protein correlates with increased tumor cell proliferation and poor patient outcome in patients with vertical growth phase melanoma. (Abstract no. P-487). (ekstern lenke)
• Straume, Oddbjørn; Salvesen, Helga; Akslen, Lars A. (1999). Angiogenesis is prognostically important in vertical growth phase melanomas. (ekstern lenke)

Vitenskapelig Kapittel/Artikkel/Konferanseartikkel

• Dillekås, Hanna; Schuster, Cornelia; Davidsen, Kjersti et al. (2022). The Role of the Microenvironment in Tumor Promoting Stress Responses. (ekstern lenke)
• Straume, Oddbjørn; Schuster, Cornelia (2017). The Tumor Microenvironment in Cutaneous Melanoma: Friend or Foe. (ekstern lenke)

Brev til redaktøren

• Sommerfelt, Hanne; Sandvik, Lene Frøyen; Bachmann, Ingeborg Margrethe et al. (2022). Toxic epidermal necrolysis after immune checkpoint inhibition, case report, and review of the literature. (ekstern lenke)
• Straume, Oddbjørn; Bergheim, Jann; Ernst, Peter (2006). Bevacizumab therapy for POEMS syndrome. (ekstern lenke)

Doktorgradsavhandling

• Dillekås, Hanna; Jensen, Svein Arthur Hønsi; Straume, Oddbjørn (2020). Importance of physical trauma on recurrence of breast cancer. (ekstern lenke)
• Schuster, Cornelia; Straume, Oddbjørn (2016). Investigation of predictive markers in patients with metastatic melanoma treated with bevacizumab. (ekstern lenke)
• Straume, Oddbjørn (2002). Biological and prognostic markers in cutaneous malignant melanoma. (ekstern lenke)

Poster

• Dillekås, Hanna; Kristoffersen, Camilla; Jensen, Svein Arthur et al. (2019). Perioperative factors and complications after delayed reconstruction in breast cancer patients in relation to oncologic outcome. (ekstern lenke)
• Demicheli, Romano; Dillekås, Hanna; Straume, Oddbjørn et al. (2018). Surgeries reveal details of metastasis development. (ekstern lenke)
• Pilskog, Martin; Straume, Oddbjørn (2017). Predictive value of IL6Rα in patients with metastatic clear cell renal cell carcinoma treated with sunitinib. (ekstern lenke)
• Pilskog, Martin; Beisland, Christian; Straume, Oddbjørn (2015). C-reactive protein as a predictive marker of response to sunitinib treatment in metastatic clear cell renal cell carcinoma. (ekstern lenke)
• Straume, Oddbjørn; Shimamura, Takeshi; Øyan, Anne Margrete et al. (2009). Suppression of heat shock Protein 27 induces long-term dormancy in human breast cancer. (ekstern lenke)

Sammendrag/abstract

• Schuster, Cornelia; Gausdal, Gro; Gjertsen, Bjørn Tore et al. (2018). Update on the randomised phase Ib/II study of the selective small molecule AXL inhibitor bemcentinib (BGB324) in combination with either dabrafenib/trametinib or pembrolizumab in patients with metastatic melanoma. (ekstern lenke)

Faglig kapittel

• Christoffersen, Thoralf; Helland, Åslaug; Engebråten, Olav et al. (2016). Signalhemmere. (ekstern lenke)

Vitenskapelig foredrag

• Dillekås, Hanna; Demicheli, Romano; Ardoino, Ilaria et al. (2016). Hva betyr sekundær rekonstruksjon for senere tilbakefall?. (ekstern lenke)
• Dillekås, Hanna; Demicheli, Romano; Ardoino, Ilaria et al. (2016). Recurrence of breast cancer in relation to delayed reconstruction. (ekstern lenke)
• Straume, Oddbjørn (2013). Nye behandlingsformer for inoperabelt metastatisk malignt melanom. (ekstern lenke)
• Straume, Oddbjørn (2013). Angiogenesis as a treatment target in melanoma. (ekstern lenke)
• Molven, Anders; Immervold, H; Kugarajh, K et al. (2003). Mutation analysis of the RAS-RAF pathway in pancreatic adenocarcinomas and malignant melanomas. (ekstern lenke)

Lærebok

• Straume, Oddbjørn; Geisler, Jürgen; Gullestad, Hans Petter et al. (2016). MEDIKAMENTELL KREFTBEHANDLING - Cytostatikaboken 8. utgave, Kapittel 34 - Malignt melanom. (ekstern lenke)

Faglig foredrag

• Straume, Oddbjørn (2013). Angiogenesis as a treatment target in metastatic melanoma. (ekstern lenke)

Short communication

• Straume, Oddbjørn; Akslen, Lars A. (2004). Lymphatic vessel density and prognosis in cutaneous melanoma. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin